A 30mg vial with 3ml of water provides a 10mg/ml concentration that delivers clean doses at the 5mg, 7.5mg, 10mg, and even 12.5mg levels
These drugs have their drawbacks, though, including cost
These advances in disease mechanism research provide the basis for the design of drugs such as rapamycin (mTOR) inhibitors (tuberous sclerosis 22 and fragile X syndrome, 23,24 ) metabolic glutamate receptor (mGluR) antagonists (fragile X syndrome 25 and 16p11.2 deletion 26 ), and insulin growth factor (IGF-1) (Rett syndrome 27 and PhelanMcDermid syndrome 28,29 )
Sometimes Interstitial Cystitis/Bladder Pain Syndrome is simply classified as Hunners lesions (5-10% of cases) and non-ulcerative Interstitial Cystitis/Bladder Pain Syndrome (the remaining 90% of cases)
The goal extends beyond weight loss or glucose controlwe aim for sustainable metabolic improvement
Your insurance will not cover peptide therapy